<p>根据 Handelsbanken Fonder AB 最近向证券交易委员会提交的文件，该公司在 2023 年第四季度将其在 HCA Healthcare, Inc.（纽约证券交易所代码：HCA - 免费报告）的股份增加了 7.9%。该机构投资者在本季度购买了额外的 15,675 股后，持有 213,272 股该公司的股票。到最近报告期末，Handelsbanken Fonder AB 持有 HCA Healthcare 约 0.09% 的股份，价值 99,568,000 美元。</p>
<p>获取 <strong>HCA Healthcare</strong> 警报：</p>
<ul>
<li>美国老龄化可能使 HCA Healthcare 成为长期赢家</li>
</ul>
<p>其他对冲基金也增加或减少了在该公司的股份。Holos Integrated Wealth LLC 在第四季度购买了价值约 29,000 美元的 HCA Healthcare 新头寸。Palisade Asset Management LLC 在第三季度购买了价值约 26,000 美元的 HCA Healthcare 新股份。Ares Financial Consulting LLC 在第四季度购买了价值约 31,000 美元的 HCA Healthcare 新股份。Aventura Private Wealth LLC 在第四季度购买了价值约 34,000 美元的 HCA Healthcare 新股份。最后，Key Capital Management INC 在第四季度购买了价值约 35,000 美元的 HCA Healthcare 新股份。对冲基金和其他机构投资者持有该公司 62.73% 的股份。</p>
<h2>HCA Healthcare 股票表现</h2>
<p>HCA 股票周二开盘价为 422.60 美元。HCA Healthcare, Inc.的 52 周低点为 330.00 美元，52 周高点为 556.52 美元。该股票的 50 日移动平均价格为 476.49 美元，200 日移动平均价格为 485.66 美元。该公司的市值为 937.5 亿美元，市盈率为 14.53，PEG 比率为 1.34，贝塔值为 1.18。</p>
<ul>
<li>该 ETF 证明医疗保健反弹是真实的</li>
</ul>
<p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）最近于 4 月 24 日（星期五）公布了季度财报。该公司报告本季度每股收益为 7.15 美元，低于市场共识预期的 7.19 美元（差额为 0.04 美元）。HCA Healthcare 的净利润率为 8.89%，股本回报率为负 295.93%。该公司本季度的收入为 191.1 亿美元，而市场共识预期为 190.9 亿美元。在去年同期，该公司的每股收益为 6.45 美元。与去年同期相比，该公司的季度收入增长了 4.3%。HCA Healthcare 已将其 2026 财年的指导目标设定为 29.100-31.500 每股收益。整体来看，股票分析师预测 HCA Healthcare, Inc.在当前年度的每股收益将达到 30.07 美元。</p>
<h2>HCA Healthcare 股息公告</h2>
<p>该公司最近还披露了季度股息，将于 6 月 30 日（星期二）支付。6 月 16 日（星期二）的股东将获得 0.78 美元的股息。除息日期为 6 月 16 日（星期二）。这代表着每年 3.12 美元的股息，收益率为 0.7%。HCA Healthcare 的派息比率目前为 10.73%。</p>
<h2>内部活动</h2>
<ul>
<li>MarketBeat 周回顾 – 07/28 - 08/01</li>
</ul>
<p>在其他新闻中，执行副总裁 Michael R. Mcalevey 于 2 月 18 日（星期三）出售了 1,694 股该公司的股票。该股票以平均价格 533.37 美元出售，总交易额为 903,528.78 美元。交易后，该执行副总裁直接持有 8,853 股该公司的股票，价值约为 4,721,924.61 美元。此次交易使其持股减少了 16.06%。该交易已在向证券交易委员会的文件中披露，相关文件可通过此链接访问。公司内部人士持有该公司 1.50% 的股份。</p>
<h2>分析师评级变动</h2>
<p>HCA 一直是多份研究分析报告的主题。瑞银集团在 2 月 23 日（星期一）的研究报告中将 HCA Healthcare 的目标价从 598.00 美元上调至 635.00 美元，并给予该公司 “买入” 评级。高盛集团在 1 月 28 日（星期三）的研究报告中将 HCA Healthcare 的目标价从 520.00 美元上调至 558.00 美元，并给予该公司 “买入” 评级。TD Cowen 在 4 月 27 日（星期一）的研究报告中将 HCA Healthcare 的目标价从 561.00 美元下调至 500.00 美元，并为该公司设定了 “买入” 评级。杰富瑞金融集团在 4 月 24 日（星期五）的研究报告中重申了 “买入” 评级，并对 HCA Healthcare 的股票设定了 525.00 美元的目标价。最后，加拿大皇家银行在 4 月 27 日（星期一）的研究报告中将 HCA Healthcare 的目标价从 593.00 美元下调至 534.00 美元，并为该公司设定了 “跑赢大盘” 评级。十六位股票研究分析师对该股票给予了 “买入” 评级，七位给予了 “持有” 评级，一位对该公司的股票给予了 “卖出” 评级。根据 MarketBeat，HCA Healthcare 目前的平均评级为 “适度买入”，平均目标价为 517.82 美元。</p>
<p><strong>阅读我们关于 HCA Healthcare 的最新研究报告</strong></p>
<h2>HCA Healthcare 简介</h2>
<p>（免费报告）</p>
<p>HCA Healthcare 是一家以盈利为目的的医疗设施运营商，总部位于田纳西州纳什维尔。该公司成立于 1968 年，拥有并运营一系列医院和相关医疗设施，并通过有机扩张和收购发展成为大型住院和门诊服务提供商。</p>
<p>该公司的核心业务包括急性护理医院、独立外科和急救中心以及门诊诊所的运营。HCA 的服务涵盖住院护理、外科服务、急救医学、诊断成像和实验室检测，以及各种门诊和门诊护理服务。</p>
<h2>另请参阅</h2>
<ul>
<li>我们更看好的五只股票比 HCA Healthcare 更好</li>
<li>为什么应用光电股票可能接近转折点</li>
<li>从高收益到高增长：三只提升股息的股票</li>
<li>Everspin Technologies 会是下一个 AI 边缘突破吗？</li>
<li>5 只机器人股票值得关注，因为物理 AI 正在蓬勃发展</li>
</ul>
<p><strong>想知道其他对冲基金持有 HCA 的情况吗？</strong> 请访问 HoldingsChannel.com 获取 HCA Healthcare, Inc. (NYSE:HCA - 免费报告) 的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 HCA Healthcare 吗？</h2>
<p>在考虑 HCA Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 HCA Healthcare 并不在名单上。</p>
<p>虽然 HCA Healthcare 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

HCA控股

医疗业 ETF - SPDR

美国医疗保健供应商 ETF - iShares

医疗业 ETF - Vanguard

标普医疗保健服务 ETF - SPDR

标普全球医疗股指数 ETF - iShares

<p>Handelsbanken Fonder AB 在第四季度增持了 HCA Healthcare, Inc. 的股份，增幅为 7.9%，目前持有 213,272 股，价值约为 9957 万美元。其他对冲基金也调整了他们的持仓。HCA 的股票开盘价为 422.60 美元，市值为 937.5 亿美元。该公司报告第一季度每股收益为 7.15 美元，略低于预期，并宣布季度股息为 0.78 美元。分析师们的目标价格各不相同，瑞银将其目标价上调至 635.00 美元</p>

<p>Handelsbanken Fonder AB raised its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 7.9% in the fourth quarter, according to its most recent filing with the Securities &amp; Exchange Commission. The institutional investor owned 213,272 shares of the company's stock after buying an additional 15,675 shares during the quarter. Handelsbanken Fonder AB owned about 0.09% of HCA Healthcare worth $99,568,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>根据 Handelsbanken Fonder AB 最近向证券交易委员会提交的文件，该公司在 2023 年第四季度将其在 HCA Healthcare, Inc.（纽约证券交易所代码：HCA - 免费报告）的股份增加了 7.9%。该机构投资者在本季度购买了额外的 15,675 股后，持有 213,272 股该公司的股票。到最近报告期末，Handelsbanken Fonder AB 持有 HCA Healthcare 约 0.09% 的股份，价值 99,568,000 美元。</p>
</div><p>Get <strong>HCA Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>HCA Healthcare</strong> 警报：</p>
</div><ul>
<li>The Aging of America Could Make HCA Healthcare a Long-Term Winner</li>
</ul>
<div class="lb-trans"><ul>
<li>美国老龄化可能使 HCA Healthcare 成为长期赢家</li>
</ul>
</div><p>Other hedge funds have also added to or reduced their stakes in the company. Holos Integrated Wealth LLC purchased a new position in HCA Healthcare during the 4th quarter valued at about $29,000. Palisade Asset Management LLC bought a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $26,000. Ares Financial Consulting LLC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at about $31,000. Aventura Private Wealth LLC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at about $34,000. Finally, Key Capital Management INC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at about $35,000. Hedge funds and other institutional investors own 62.73% of the company's stock.</p>
<div class="lb-trans"><p>其他对冲基金也增加或减少了在该公司的股份。Holos Integrated Wealth LLC 在第四季度购买了价值约 29,000 美元的 HCA Healthcare 新头寸。Palisade Asset Management LLC 在第三季度购买了价值约 26,000 美元的 HCA Healthcare 新股份。Ares Financial Consulting LLC 在第四季度购买了价值约 31,000 美元的 HCA Healthcare 新股份。Aventura Private Wealth LLC 在第四季度购买了价值约 34,000 美元的 HCA Healthcare 新股份。最后，Key Capital Management INC 在第四季度购买了价值约 35,000 美元的 HCA Healthcare 新股份。对冲基金和其他机构投资者持有该公司 62.73% 的股份。</p>
</div><h2>HCA Healthcare Stock Performance</h2>
<div class="lb-trans"><h2>HCA Healthcare 股票表现</h2>
</div><p>Shares of HCA stock opened at $422.60 on Tuesday. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The stock has a 50 day moving average price of $476.49 and a two-hundred day moving average price of $485.66. The company has a market capitalization of $93.75 billion, a P/E ratio of 14.53, a PEG ratio of 1.34 and a beta of 1.18.</p>
<div class="lb-trans"><p>HCA 股票周二开盘价为 422.60 美元。HCA Healthcare, Inc.的 52 周低点为 330.00 美元，52 周高点为 556.52 美元。该股票的 50 日移动平均价格为 476.49 美元，200 日移动平均价格为 485.66 美元。该公司的市值为 937.5 亿美元，市盈率为 14.53，PEG 比率为 1.34，贝塔值为 1.18。</p>
</div><ul>
<li>This ETF Is Proof That the Healthcare Rebound Is Real</li>
</ul>
<div class="lb-trans"><ul>
<li>该 ETF 证明医疗保健反弹是真实的</li>
</ul>
</div><p>HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter in the previous year, the firm posted $6.45 EPS. The business's revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.</p>
<div class="lb-trans"><p>HCA Healthcare（纽约证券交易所代码：HCA - 获取免费报告）最近于 4 月 24 日（星期五）公布了季度财报。该公司报告本季度每股收益为 7.15 美元，低于市场共识预期的 7.19 美元（差额为 0.04 美元）。HCA Healthcare 的净利润率为 8.89%，股本回报率为负 295.93%。该公司本季度的收入为 191.1 亿美元，而市场共识预期为 190.9 亿美元。在去年同期，该公司的每股收益为 6.45 美元。与去年同期相比，该公司的季度收入增长了 4.3%。HCA Healthcare 已将其 2026 财年的指导目标设定为 29.100-31.500 每股收益。整体来看，股票分析师预测 HCA Healthcare, Inc.在当前年度的每股收益将达到 30.07 美元。</p>
</div><h2>HCA Healthcare Dividend Announcement</h2>
<div class="lb-trans"><h2>HCA Healthcare 股息公告</h2>
</div><p>The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare's payout ratio is presently 10.73%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度股息，将于 6 月 30 日（星期二）支付。6 月 16 日（星期二）的股东将获得 0.78 美元的股息。除息日期为 6 月 16 日（星期二）。这代表着每年 3.12 美元的股息，收益率为 0.7%。HCA Healthcare 的派息比率目前为 10.73%。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><ul>
<li>MarketBeat Week in Review – 07/28 - 08/01</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 07/28 - 08/01</li>
</ul>
</div><p>In other news, EVP Michael R. Mcalevey sold 1,694 shares of the business's stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares of the company's stock, valued at approximately $4,721,924.61. The trade was a 16.06% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.50% of the company's stock.</p>
<div class="lb-trans"><p>在其他新闻中，执行副总裁 Michael R. Mcalevey 于 2 月 18 日（星期三）出售了 1,694 股该公司的股票。该股票以平均价格 533.37 美元出售，总交易额为 903,528.78 美元。交易后，该执行副总裁直接持有 8,853 股该公司的股票，价值约为 4,721,924.61 美元。此次交易使其持股减少了 16.06%。该交易已在向证券交易委员会的文件中披露，相关文件可通过此链接访问。公司内部人士持有该公司 1.50% 的股份。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>HCA has been the subject of a number of research analyst reports. UBS Group lifted their price target on HCA Healthcare from $598.00 to $635.00 and gave the company a &#34;buy&#34; rating in a research report on Monday, February 23rd. The Goldman Sachs Group lifted their price target on HCA Healthcare from $520.00 to $558.00 and gave the company a &#34;buy&#34; rating in a research report on Wednesday, January 28th. TD Cowen dropped their target price on HCA Healthcare from $561.00 to $500.00 and set a &#34;buy&#34; rating for the company in a research report on Monday, April 27th. Jefferies Financial Group restated a &#34;buy&#34; rating and issued a $525.00 target price on shares of HCA Healthcare in a research report on Friday, April 24th. Finally, Royal Bank Of Canada dropped their target price on HCA Healthcare from $593.00 to $534.00 and set an &#34;outperform&#34; rating for the company in a research report on Monday, April 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, HCA Healthcare currently has an average rating of &#34;Moderate Buy&#34; and an average target price of $517.82.</p>
<div class="lb-trans"><p>HCA 一直是多份研究分析报告的主题。瑞银集团在 2 月 23 日（星期一）的研究报告中将 HCA Healthcare 的目标价从 598.00 美元上调至 635.00 美元，并给予该公司 “买入” 评级。高盛集团在 1 月 28 日（星期三）的研究报告中将 HCA Healthcare 的目标价从 520.00 美元上调至 558.00 美元，并给予该公司 “买入” 评级。TD Cowen 在 4 月 27 日（星期一）的研究报告中将 HCA Healthcare 的目标价从 561.00 美元下调至 500.00 美元，并为该公司设定了 “买入” 评级。杰富瑞金融集团在 4 月 24 日（星期五）的研究报告中重申了 “买入” 评级，并对 HCA Healthcare 的股票设定了 525.00 美元的目标价。最后，加拿大皇家银行在 4 月 27 日（星期一）的研究报告中将 HCA Healthcare 的目标价从 593.00 美元下调至 534.00 美元，并为该公司设定了 “跑赢大盘” 评级。十六位股票研究分析师对该股票给予了 “买入” 评级，七位给予了 “持有” 评级，一位对该公司的股票给予了 “卖出” 评级。根据 MarketBeat，HCA Healthcare 目前的平均评级为 “适度买入”，平均目标价为 517.82 美元。</p>
</div><p><strong>Read Our Latest Research Report on HCA Healthcare</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 HCA Healthcare 的最新研究报告</strong></p>
</div><h2>HCA Healthcare Profile</h2>
<div class="lb-trans"><h2>HCA Healthcare 简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.</p>
<div class="lb-trans"><p>HCA Healthcare 是一家以盈利为目的的医疗设施运营商，总部位于田纳西州纳什维尔。该公司成立于 1968 年，拥有并运营一系列医院和相关医疗设施，并通过有机扩张和收购发展成为大型住院和门诊服务提供商。</p>
</div><p>The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.</p>
<div class="lb-trans"><p>该公司的核心业务包括急性护理医院、独立外科和急救中心以及门诊诊所的运营。HCA 的服务涵盖住院护理、外科服务、急救医学、诊断成像和实验室检测，以及各种门诊和门诊护理服务。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另请参阅</h2>
</div><ul>
<li>Five stocks we like better than HCA Healthcare</li>
<li>Why Applied Optoelectronics Stock May Be Near a Turning Point</li>
<li>From High-Yield to High-Growth: 3 Stocks Boosting Dividends</li>
<li>Is Everspin Technologies the Next AI Edge Breakout?</li>
<li>5 Robotics Stocks to Watch as Physical AI Builds Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 HCA Healthcare 更好</li>
<li>为什么应用光电股票可能接近转折点</li>
<li>从高收益到高增长：三只提升股息的股票</li>
<li>Everspin Technologies 会是下一个 AI 边缘突破吗？</li>
<li>5 只机器人股票值得关注，因为物理 AI 正在蓬勃发展</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding HCA?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他对冲基金持有 HCA 的情况吗？</strong> 请访问 HoldingsChannel.com 获取 HCA Healthcare, Inc. (NYSE:HCA - 免费报告) 的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=HCA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in HCA Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 HCA Healthcare 吗？</h2>
</div><p>Before you consider HCA Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 HCA Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 HCA Healthcare 并不在名单上。</p>
</div><p>While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 HCA Healthcare 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Handelsbanken Fonder AB Boosts Position in HCA Healthcare, Inc. $HCA

Market Beat

瑞银集团

高盛

Toronto Dominion Bank

Jefferies Financial

加拿大皇家银行

GS Hldg R

Handelsbanken Fonder AB 增加了在 HCA Healthcare, Inc. $HCA 的持股比例